More than one-third of the population has at least one cardiometabolic risk factor - dyslipidemia, CVD, hypertension, diabetes, and/or obesity. Now in its 13th year, the Cardiometabolic Health Congress is the largest, US-based, multidisciplinary conference focused solely on the management of cardiometabolic risk and the prevention of cardiovascular and metabolic disease. The 3 ½- day event offers today's busy healthcare professionals a one-of-a-kind opportunity to learn real-world solutions they can integrate immediately into their clinical practices.
Metabolic Syndrome and Related Disorders is the only peer-reviewed journal focusing solely on the pathophysiology, recognition, and treatment of this major health condition. The Journal meets the imperative for comprehensive research, data, and commentary on metabolic disorder as a suspected precursor to a wide range of diseases, including type 2 diabetes, cardiovascular disease, stroke, cancer, polycystic ovary syndrome, gout, and asthma.
Pick up your copy at the 2018 CMHC!